Revolutionizing biomarker research with Olink technology

Hear from Professor Guillaume Paré from McMaster University, as he discusses the critical shift away from the traditional 'one biomarker, one disease' paradigm. He advocates for a more dynamic view of biomarkers, particularly focusing on protein signatures that can support better disease understanding and therapy development.

Olink is paving the way with its PEA technology to support the analysis of 5–5400+ proteins simultaneously. By working with an Olink Certified Service Provider such as CRLB-GMEL headed by Professor Guillaume Paré, investigators are enabled to redefine the boundaries of medical research and gain unique insights into disease biology, aiding the identification of new therapeutic targets and biomarkers.